Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura

Subjects

Subjects :

Diseases of the blood and blood-forming organs
RC633-647.5

Details

Language :

English

ISSN :

25311379

Volume :

42

Issue :

62-63

Database :

Directory of Open Access Journals

Journal :

Hematology, Transfusion and Cell Therapy

Publication Type :

Academic Journal

Accession number :

edsdoj.86642bdc87514c7db7e170709e05ebc8

Document Type :

article

Full Text :

https://doi.org/10.1016/j.htct.2020.09.112